Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Polli

Showing results (381-390 of 420) with videos related to

Pageof 42
Sort By:
Journal of Pharmaceutical Sciences|September 24, 2016
Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring GridPaul A Dickinson, Filippos Kesisoglou, Talia Flanagan, et al.
Clinical Pharmacology and Therapeutics|October 17, 2022
Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop SummarySophie Shubow, Qin Sun, Ai Len Nguyen Phan, et al.
Journal of Pharmaceutical Sciences|October 1, 2021
Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Sitagliptin Phosphate MonohydrateNaseem A Charoo, Daud B Abdallah, Ahmed Abdalla Bakheit, et al.
Journal of Pharmaceutical Sciences|November 27, 2025
Biowaiver monograph for immediate-release solid oral dosage forms: Amlodipine besylatePorfirio de la Cruz-Cruz, Mauricio A García, José Trinidad Pérez-Urizar, et al.
Biological Psychiatry|August 12, 2014
Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depressionMichael T Treadway, Michael L Waskom, Daniel G Dillon, et al.
Molecular Pharmaceutics|April 11, 2024
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary ReportClaire Mackie, Sumit Arora, Paul Seo, et al.
Molecular Pharmaceutics|January 25, 2019
Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric ApproachHeather M Neu, Sergei A Alexishin, Joel E P Brandis, et al.
Journal of Pharmaceutical Sciences|August 27, 2017
Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Folic AcidMartin A Hofsäss, Jacqueline de Souza, Neila M Silva-Barcellos, et al.
Journal of Pharmaceutical Sciences|September 27, 2014
The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performanceArzu Selen, Paul A Dickinson, Anette Müllertz, et al.
The AAPS Journal|June 12, 2012
Summary workshop report: Facilitating oral product development and reducing regulatory burden through novel approaches to assess bioavailability/bioequivalenceJames E Polli, Jack A Cook, Barbara M Davit, et al.
Pageof 42

Showing results (381-390 of 420) with videos related to

Sort By:
Pageof 42
Journal of Pharmaceutical Sciences|September 24, 2016
Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring GridPaul A Dickinson, Filippos Kesisoglou, Talia Flanagan, et al.
Clinical Pharmacology and Therapeutics|October 17, 2022
Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop SummarySophie Shubow, Qin Sun, Ai Len Nguyen Phan, et al.
Journal of Pharmaceutical Sciences|October 1, 2021
Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Sitagliptin Phosphate MonohydrateNaseem A Charoo, Daud B Abdallah, Ahmed Abdalla Bakheit, et al.
Journal of Pharmaceutical Sciences|November 27, 2025
Biowaiver monograph for immediate-release solid oral dosage forms: Amlodipine besylatePorfirio de la Cruz-Cruz, Mauricio A García, José Trinidad Pérez-Urizar, et al.
Biological Psychiatry|August 12, 2014
Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depressionMichael T Treadway, Michael L Waskom, Daniel G Dillon, et al.
Molecular Pharmaceutics|April 11, 2024
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary ReportClaire Mackie, Sumit Arora, Paul Seo, et al.
Molecular Pharmaceutics|January 25, 2019
Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric ApproachHeather M Neu, Sergei A Alexishin, Joel E P Brandis, et al.
Journal of Pharmaceutical Sciences|August 27, 2017
Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Folic AcidMartin A Hofsäss, Jacqueline de Souza, Neila M Silva-Barcellos, et al.
Journal of Pharmaceutical Sciences|September 27, 2014
The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performanceArzu Selen, Paul A Dickinson, Anette Müllertz, et al.
The AAPS Journal|June 12, 2012
Summary workshop report: Facilitating oral product development and reducing regulatory burden through novel approaches to assess bioavailability/bioequivalenceJames E Polli, Jack A Cook, Barbara M Davit, et al.
Pageof 42